Parametric Risk Advisors’s Biogen BIIB Stock Holding History

Parametric Risk Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7,000	Closed	-$1.69M	–	114
2016 Q2	$1.69M	Hold	7,000	–	–	0.11%	94
2016 Q1	$1.82M	Hold	7,000	–	–	0.12%	83
2015 Q4	$2.14M	Hold	7,000	–	–	0.15%	74
2015 Q3	$2.04M	Hold	7,000	–	–	0.13%	74
2015 Q2	$2.83M	Hold	7,000	–	–	0.19%	66
2015 Q1	$2.96M	Sell	7,000 -614	-8%	-$242K	0.2%	67
2014 Q4	$2.58M	Sell	7,614 -1,035	-12%	-$335K	0.17%	74
2014 Q3	$2.86M	Buy	8,649 +7,794	+912%	+$2.57M	0.19%	72
2014 Q2	$270K	Hold	855	–	–	0.02%	144
2014 Q1	$262K	Buy	855 +538	+170%	+$171K	0.02%	151
2013 Q4	$89K	Buy	+317	New	+$82K	0.01%	149

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parametric Risk Advisors's BIIB Position: Q3 2016 in Review

Parametric Risk Advisors sold out of Biogen (BIIB) in Q3 2016, closing a stake of 7,000 shares — an estimated $1.69M sold.

Parametric Risk Advisors first reported a position in BIIB in Q4 2013 and held it in 11 quarters. The position peaked at $2.96M in Q1 2015. 1,012 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

Parametric Risk Advisors reported no remaining Biogen position as of Q3 2016 after selling out during the quarter.
Parametric Risk Advisors sold 7,000 Biogen shares in Q3 2016, an estimated $1.69M.
Parametric Risk Advisors first reported a position in Biogen in Q4 2013 and held it in 11 quarters.
Parametric Risk Advisors's Biogen position peaked at $2.96M in Q1 2015.
1,012 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on Parametric Risk Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.